Oral GLP-1 Dissolving Tablets: Sublingual Semaglutide vs Injections Guide

1. How Sublingual Mucosal Absorption Works

Semaglutide is a complex 31-amino acid peptide with a fatty diacid side chain. If swallowed directly like a conventional aspirin tablet, it is promptly cleaved and rendered inert by gastric pepsin and stomach hydrochloric acid.

Sublingual formulations overcome this barrier by exploiting the anatomy of the oral mucosa. The non-keratinized epithelial tissue beneath the tongue is only 100 to 200 micrometers thick and lies directly above an intricate web of capillaries and veins connecting to the internal jugular vein.

Compounded sublingual tablets incorporate specialized hydrophilic permeation enhancers and bioadhesive matrices. As the tablet dissolves under the tongue over 2 to 5 minutes, the semaglutide molecules permeate the intercellular lipid bilayers and enter systemic blood circulation directly—achieving therapeutic circulating levels without passing through the harsh digestive tract or liver.

2. Administration Rules for Maximum Bioavailability

Proper administration is the single most important factor determining success on oral GLP-1 therapy:

1. Administer First Thing in the Morning: Place the tablet directly beneath the tongue upon waking.
2. Do Not Chew or Swallow Whole: Allow the tablet to dissolve naturally for at least 3 to 5 minutes without swallowing saliva prematurely.
3. The 30-Minute Fasting Window: Do not drink water, coffee, or eat breakfast for 30 minutes following administration to avoid flushing active medication away from the sublingual vascular bed.

3. Dosage Escalation & Steady-State Kinetics

Because sublingual tablets are administered daily rather than in a weekly bolus, plasma concentrations remain remarkably steady. Patients avoid the sharp pharmacokinetic peak on Days 2 and 3 post-injection that triggers severe nausea, as well as the Day 6 and 7 "trough" where hunger signals return: